Development and validation of the actionable bladder symptom screening tool for multiple sclerosis patients
about
Patient reported outcome measures in neurogenic bladderSecondary and tertiary treatments for multiple sclerosis patients with urinary symptomsDevelopment of a short form and scoring algorithm from the validated actionable bladder symptom screening tool.Validation of a bladder symptom screening tool in women with incontinence due to overactive bladderTablet-based screening improves continence management in multiple sclerosisSimplified scoring of the Actionable 8-item screening questionnaire for neurogenic bladder overactivity in multiple sclerosis: a comparative analysis of test performance at different cut-off pointsValidation of a Dutch version of the Actionable 8-item screening questionnaire for neurogenic bladder overactivity in multiple sclerosis: an observational web-based studyThe interactive web-based program MSmonitor for self-management and multidisciplinary care in multiple sclerosis: concept, content, and pilot results.The interactive web-based program MSmonitor for self-management and multidisciplinary care in multiple sclerosis: utilization and valuation by patients.Management of neurogenic lower urinary tract dysfunction in multiple sclerosis patients.Evaluation of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelines.Barriers experienced by patients with multiple sclerosis in seeking care for lower urinary tract symptoms.Effects of daily tadalafil on lower urinary tract symptoms in young men with multiple sclerosis and erectile dysfunction: a pilot study.Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances.
P2860
Q26767322-73A6575E-220C-4F5B-AD75-7FA82076E9F0Q28070040-73D0529A-461E-4096-B9BA-B01DD98A13BFQ30541961-F9C38DC2-9178-481A-8A99-0FF99923B7F3Q34528375-36C866CC-F587-4305-8EA7-76D3F8F6F01DQ35777277-8D53C525-4DBE-4ED2-87C2-175928129183Q35820089-4279AA17-931C-476B-B65B-4407066063BAQ36235033-E17235F3-3898-4CC5-9E72-911DD4220792Q36389736-ED1B131E-0E0C-472A-9EBA-BFE54FAF36D1Q36658225-4BF7A220-1973-4319-A890-DE4491E7C730Q38508246-19F88635-0468-4B57-93D2-96AC6CF9B9C8Q39262833-AFDB41C5-0235-44A7-AAA5-E634D89C47ACQ46190605-D17C75B6-EFBF-4FB8-9692-063F73AEEE41Q48771187-830481E4-6BDA-4904-9041-1744EA4B81D0Q50764775-916226C9-D521-455D-9F86-766894FD9FE5
P2860
Development and validation of the actionable bladder symptom screening tool for multiple sclerosis patients
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development and validation of ...... or multiple sclerosis patients
@en
Development and validation of ...... r multiple sclerosis patients.
@nl
type
label
Development and validation of ...... or multiple sclerosis patients
@en
Development and validation of ...... r multiple sclerosis patients.
@nl
prefLabel
Development and validation of ...... or multiple sclerosis patients
@en
Development and validation of ...... r multiple sclerosis patients.
@nl
P2093
P2860
P1476
Development and validation of ...... or multiple sclerosis patients
@en
P2093
Amy Perrin Ross
David Bates
Denise Globe
Ib Odderson
Jack Burks
Jalesh Panicker
Manuel Signori
Michael Chancellor
Pierre Denys
Scott Macdiarmid
P2860
P304
P356
10.7224/1537-2073.2012-049
P577
2013-01-01T00:00:00Z